Menu
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

BioCryst Pharmaceuticals, Inc. - Common Stock (NQ:BCRX)

8.410 -0.060 (-0.71%)
Streaming Delayed Price Updated: 4:00 PM EDT, Jun 5, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about BioCryst Pharmaceuticals, Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 8 Next >
News headline image
Mid-Day Market Update: Dow Jumps Over 200 Points; Sunshine Biopharma Shares Slide ↗
U.S. stocks traded mixed midway through trading, with the Dow Jones surging more than 200 points on Friday. 
Via Benzinga
News headline image
Read Here Why Did BioCryst Stopped Enrollment In BCX9930 Studies In Rare Blood Disorder ↗
 
Via Benzinga
News headline image
Mid-Morning Market Update: Markets Edge Lower; US Wholesale Inventories Rise 2.5% In February ↗
U.S. stocks traded mostly lower this morning, with the Nasdaq Composite dropping 100 points on Friday. 
Via Benzinga
News headline image
Why BioCryst Pharmaceuticals Stock Is Plunging Today ↗
BioCryst Pharmaceuticals Inc (NASDAQ: BCRX) shares are trading significantly lower Friday after the company paused enrollment in clinical trials with BCX9930 while it ... 
Via Benzinga
News headline image
Biocryst Pharmaceuticals Stock Shows Rising Price Performance With Jump To 92 RS Rating ↗
Biotech Biocryst Pharmaceuticals stock had its Relative Strength (RS) Rating upgraded from 88 to 92 Wednesday. 
Via Investor's Business Daily
News headline image
Can Recent Catalysts Breakout BioCryst To New Highs? ↗
In today’s volatile markets, finding a biotech stock that isn’t purely speculative can be challenging, and yet BCRX may have what it takes. 
Via Talk Markets
News headline image
BioCryst Is On Fire: What Do Options Traders Expect Next? ↗
Shares of BioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX) sur... 
Via Benzinga
News headline image
BioCryst Continues To Develop A Strong Pipeline ↗
Investing in biotech stocks often comes with huge risks and rewards, as a company is dependent on its pipeline and royalty payments. 
Via Talk Markets
News headline image
BioCryst's Orladeyo Shows Long Term Benefit With Sustained Reductions in Attack Rates ↗
BioCryst Pharmaceuticals Inc (NASDAQ: BCRX) announced new long-term efficacy and safety data from the APeX-2 trial evaluating Orladeyo (berotralstat) for the... 
Via Benzinga
News headline image
Recap: BioCryst Pharmaceuticals Q4 Earnings ↗
BioCryst Pharmaceuticals (NASDAQ:BCRX) reported its Q4 earnings results on Wednesday, February 23, 2022 at 07:00 AM. Here's what investors need to know about the... 
Via Benzinga
News headline image
BioCryst Hit 15-Year Highs But What's In Store Tomorrow For Earnings? ↗
By StoryTrading BioCryst’s (NASDAQ: BCRX) stock price hit 15-year highs since our article was published on Benzinga earlier this month, but with the oral prophylactic... 
Via Benzinga
News headline image
10 Health Care Stocks With Whale Alerts In Today's Session ↗
This whale alert can help traders discover the next big trading opportunities. Whales are entities with large sums of money and we track their transactions here at Benzinga on our options activity... 
Via Benzinga
News headline image
Is BioCryst (BCRX) Ready to Breakout to New Highs on Recent Catalysts? ↗
By Ben Rabizadeh – Fundamentals well positioned with $1B peak sales forecast for Orladeyo and $300M influx of cash from royalty deals – Potential catalysts: update on Orladeyo sales with Q4 results on... 
Via Benzinga
News headline image
If You Invested $1000 In This Stock 10 Years Ago, Here's How Much You Would Have Today ↗
BioCryst Pharmaceuticals (NASDAQ:BCRX) has outperformed the market over the past 10 years by 5.6% on an annualized basis. Buying $1,000 In BCRX: 10 years ago, an investor could... 
Via Benzinga
News headline image
60 Biggest Movers From Yesterday ↗
Gainers Bone Biologics Corporation (NASDAQ: BBLG) shares surged 57.1% to close at $5.39 on Monday. Zynga Inc. (NASDAQ: ZNGA) rose 40.7% to settle at $8.44 after the company... 
Via Benzinga
News headline image
Biotech Bloodbath Continues Despite Gene-Editing Deals For Pfizer, Bayer ↗
Pfizer and Bayer inked deals with several companies in gene-editing. 
Via Investor's Business Daily
News headline image
45 Stocks Moving In Monday's Mid-Day Session ↗
Gainers Bone Biologics Corporation (NASDAQ: BBLG) shares climbed 71.5% to $5.88. Zynga Inc. (NASDAQ: ZNGA) gained 45.7% to $8.74 after the company announced it will be acquired... 
Via Benzinga
News headline image
3 Stocks Insiders Are Buying ↗
When insiders purchase shares, it indicates their confidence in the company's prospects or that they view the stock as a bargain. Either way, t... 
Via Benzinga
News headline image
Benzinga's Top Ratings Upgrades, Downgrades For December 10, 2021 ↗
Upgrades According to JP Morgan, the prior rating for Arconic Corp (NYSE: 
Via Benzinga
News headline image
BioCryst Shares Gain As Royalty Pharma Buys Additional Interests In BCX9930, Orladeyo ↗
Royalty Pharma plc (NASDAQ: RPRX) and OMERS Capital Markets have announced transactions worth $350 million in new funding in BioCryst Pharmaceuticals... 
Via Benzinga
News headline image
7 Top Growth Stocks to Buy as We Step Into November ↗
Here are seven top growth stocks investors may want to consider when looking at options in this hyper-growth market right now. 
Via InvestorPlace
News headline image
86 Biggest Movers From Yesterday ↗
Gainers FAT Brands Inc. (NASDAQ: FATBB) shares gained 99.2% to settle at $15.44. FAT Brands recently announced plans to acquire Fazoli’s Restaurant Chain for $130 million.... 
Via Benzinga
News headline image
BioCryst Pharmaceuticals (BCRX) Q3 2021 Earnings Call Transcript ↗
BCRX earnings call for the period ending September 30, 2021. 
Via The Motley Fool
Topics Earnings
News headline image
Here's Why BioCryst Pharmaceuticals Stock Is Losing Ground Today ↗
The biotech's third quarter was a good one, once you look past the top-line numbers. 
Via The Motley Fool
News headline image
12 Health Care Stocks Moving In Wednesday's Intraday Session ↗
Gainers iRhythm Technologies (NASDAQ:IRTC) stock moved upwards by 52.78% to $117.34 during Wednesday's regular session. iRhythm Technologies's stock is trading at... 
Via Benzinga
News headline image
12 Health Care Stocks Moving In Wednesday's Pre-Market Session ↗
Gainers Glaukos (NYSE:GKOS) stock increased by 25.55% to $56.58 during Wednesday's pre-market session. The market value of their outstanding shares is at $2.6 billion... 
Via Benzinga
News headline image
12 Health Care Stocks Moving In Wednesday's After-Market Session ↗
Gainers Tenet Healthcare (NYSE:THC) stock r... 
Via Benzinga
News headline image
2 Super-Charged Growth Stocks to Buy Now ↗
These two small drugmakers are poised for a long-winded growth spurt. 
Via The Motley Fool
News headline image
NICE Recommends BioCryst's Hereditary Angioedema Med ↗
The U.K.'s National Institute for Health and Care Excellence (NICE) has recommended BioCryst Pharmaceuticals Inc's (NASDAQ: BCRX) Orladeyo (berotralstat)... 
Via Benzinga
News headline image
US Government Exercises Option To Buy Additional Doses Of BioCryst's Flu Med ↗
The U.S. Department of Health and Human Services (HHS) has exercised its option to purchase an additional 10,000 doses of BioCryst Pharmaceuticals Inc's (... 
Via Benzinga
< Previous 1 2 3 4 5 6 7 8 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.